CAM
NVO

CGOV Asset Management’s Novo Nordisk NVO Stock Holding History

CGOV Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-28,200
Closed -$679K – 60
2016
Q4 		$679K Sell
28,200
-96,600
-77% -$1.75M 0.03% 47
2016
Q3 		$3.4M Buy
+124,800
New +$3.09M 0.13% 31

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

CGOV Asset Management's NVO Position: Q1 2017 in Review

CGOV Asset Management sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 28,200 shares — an estimated $679K sold.

CGOV Asset Management first reported a position in NVO in Q3 2016 and held it in 2 quarters. The position peaked at $3.4M in Q3 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • CGOV Asset Management reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • CGOV Asset Management sold 28,200 Novo Nordisk shares in Q1 2017, an estimated $679K.
  • CGOV Asset Management first reported a position in Novo Nordisk in Q3 2016 and held it in 2 quarters.
  • CGOV Asset Management's Novo Nordisk position peaked at $3.4M in Q3 2016.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on CGOV Asset Management's 13F filing for Q1 2017, filed 17 Apr 2017.